ODI Pharma Balance Sheet Health
Financial Health criteria checks 6/6
ODI Pharma has a total shareholder equity of SEK527.1K and total debt of SEK0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are SEK6.1M and SEK5.5M respectively. ODI Pharma's EBIT is SEK1.1M making its interest coverage ratio 1.9. It has cash and short-term investments of SEK5.0M.
Key information
0%
Debt to equity ratio
SEK 0
Debt
| Interest coverage ratio | 1.9x |
| Cash | SEK 4.99m |
| Equity | SEK 527.08k |
| Total liabilities | SEK 5.55m |
| Total assets | SEK 6.08m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 6OD's short term assets (SEK6.1M) exceed its short term liabilities (SEK5.5M).
Long Term Liabilities: 6OD has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: 6OD is debt free.
Reducing Debt: 6OD has not had any debt for past 5 years.
Debt Coverage: 6OD has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: 6OD has no debt, therefore coverage of interest payments is not a concern.